BYZANPRI — 2163004
Application number
2163004
Registration number
TMA1201869
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2022-01-28
Registered
2023-10-04
Registration Expiry Date
2033-10-04
Registered Owner
Zymeworks BC Inc.
Suite 800 - 114 East 4th Avenue
Vancouver
BRITISH COLUMBIA V5T1G4
Agent
GOWLING WLG (CANADA) LLP
SUITE 1600
1 FIRST CANADIAN PLACE
100 KING STREET WEST
TORONTO
ONTARIO M5X1G5
Documents
Index headings
- BYZANPRI
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
Recordals (known also as Footnotes)
Owner Address Change / Changement d'adresse du propriétaire DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2022-03-22 CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Name / Nom DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2023-04-05 DATE OF CHANGE / DATE DE CHANGEMENT: 2022-10-13 COMMENTS / COMMENTAIRES: FROM/DE: Zymeworks Inc. TO/A: Zymeworks BC Inc.Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2022-01-28 | ||
| Created | 2022-01-28 | ||
| Formalized | 2022-01-28 | ||
| Amendment to Application | 2022-03-22 | Address/address | |
| Amendment to Application | 2023-04-05 | Name/Nom | |
| Search Recorded | 2023-06-13 | ||
| Approved | 2023-06-19 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2023-06-19 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2023-07-12 | Vol.70 Issue 3585 | |
| Registration Pending | 2023-10-04 | ||
| Registered | 2023-10-04 | 2033-10-04 |